| Title |
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
|
|---|---|
| Published in |
British Journal of Clinical Pharmacology, June 2016
|
| DOI | 10.1111/bcp.13008 |
| Pubmed ID | |
| Authors |
Folefac Aminkeng, Colin J. D. Ross, Shahrad R. Rassekh, Soomi Hwang, Michael J. Rieder, Amit P. Bhavsar, Anne Smith, Shubhayan Sanatani, Karen A. Gelmon, Daniel Bernstein, Michael R. Hayden, Ursula Amstutz, Bruce C. Carleton, CPNDS Clinical Practice Recommendations Group |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 40% |
| Unknown | 6 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 40% |
| Practitioners (doctors, other healthcare professionals) | 3 | 30% |
| Scientists | 2 | 20% |
| Science communicators (journalists, bloggers, editors) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 176 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 16% |
| Student > Master | 25 | 14% |
| Student > Ph. D. Student | 21 | 12% |
| Student > Doctoral Student | 18 | 10% |
| Student > Bachelor | 16 | 9% |
| Other | 33 | 19% |
| Unknown | 35 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 34% |
| Biochemistry, Genetics and Molecular Biology | 22 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 11% |
| Agricultural and Biological Sciences | 8 | 5% |
| Social Sciences | 4 | 2% |
| Other | 15 | 9% |
| Unknown | 48 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2021.
All research outputs
#1,694,314
of 23,577,654 outputs
Outputs from British Journal of Clinical Pharmacology
#432
of 5,214 outputs
Outputs of similar age
#32,116
of 353,732 outputs
Outputs of similar age from British Journal of Clinical Pharmacology
#21
of 88 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,214 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,732 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.